Quality, testing and Canadian shipping Every research compound in this category is produced in a cGMP-compliant facility and independently verified by third-party HPLC to at least 99% purity, with a certificate of analysis available on request
Mounjaro reduced A1C by 0.7% and led to nearly 19% weight loss
As semaglutide and tirzepatide seek to expand their approved indications, e.g., potentially adding heart failure, chronic kidney disease or MASH, following several successful phase 3 trial readouts in 2023 and 2024, more pathways open up to Medicare reimbursement of AOMs within existing rules
The BMI requirements for GLP-1 medications are important because these are prescription medications intended for people with clinically significant excess weight, not for cosmetic weight loss in people already at a healthy weight
each dose splits roughly 50/50 between the two peptides
Retatrutide must get approval from the regulatory agencies before people can use it